The design of small chimeric thrombin inhibitors based on the structure of dipetalogastin II has been previously described...
Keywords: Thrombin inhibitor, Dipetalogastin, rational drug design, chimeric protein, classical competitive kinetics
01/2007 | Thrombosis and Haemostasis, Schattauer